Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.

Marchetti A, Del Grammastro M, Filice G, Felicioni L, Rossi G, Graziano P, Sartori G, Leone A, Malatesta S, Iacono M, Guetti L, Viola P, Mucilli F, Cuccurullo F, Buttitta F.

PLoS One. 2012;7(7):e42164. doi: 10.1371/journal.pone.0042164. Epub 2012 Jul 27.

2.

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF.

J Natl Cancer Inst. 2005 Mar 2;97(5):339-46.

3.

Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).

de Biase D, Visani M, Malapelle U, Simonato F, Cesari V, Bellevicine C, Pession A, Troncone G, Fassina A, Tallini G.

PLoS One. 2013 Dec 23;8(12):e83607. doi: 10.1371/journal.pone.0083607. eCollection 2013.

4.

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T.

Cancer Res. 2004 Dec 15;64(24):8919-23.

5.

Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.

Kawahara A, Yamamoto C, Nakashima K, Azuma K, Hattori S, Kashihara M, Aizawa H, Basaki Y, Kuwano M, Kage M, Mitsudomi T, Ono M.

Clin Cancer Res. 2010 Jun 15;16(12):3163-70. doi: 10.1158/1078-0432.CCR-09-3239. Epub 2010 Apr 27.

6.

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].

Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):119-23. Chinese.

PMID:
17645848
7.

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.

Marchetti A, Del Grammastro M, Felicioni L, Malatesta S, Filice G, Centi I, De Pas T, Santoro A, Chella A, Brandes AA, Venturino P, Cuccurullo F, Crinò L, Buttitta F.

PLoS One. 2014 Aug 19;9(8):e103883. doi: 10.1371/journal.pone.0103883. eCollection 2014.

8.

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

Zupa A, Vita G, Landriscina M, Possidente L, Aieta M, Tartarone A, Improta G.

Med Oncol. 2012 Dec;29(5):3198-201. doi: 10.1007/s12032-012-0304-y. Epub 2012 Jul 8.

PMID:
22773041
9.

Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.

Kawahara A, Azuma K, Sumi A, Taira T, Nakashima K, Aikawa E, Abe H, Yamaguchi T, Takamori S, Akiba J, Kage M.

Lung Cancer. 2011 Oct;74(1):35-40. doi: 10.1016/j.lungcan.2011.02.002. Epub 2011 Mar 27.

PMID:
21444121
10.

[Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].

Dong QG, Han BH, Huang JS, Yang LM, Huang J, Zhao CY, Lu LQ.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):686-90. Chinese.

PMID:
17274376
11.

Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY.

Lung Cancer. 2012 Mar;75(3):321-5. doi: 10.1016/j.lungcan.2011.08.005. Epub 2011 Sep 17.

PMID:
21930325
12.

Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer.

Uhara M, Matsuda K, Taira C, Higuchi Y, Okumura N, Yamauchi K.

Clin Chim Acta. 2009 Mar;401(1-2):68-72. doi: 10.1016/j.cca.2008.11.018. Epub 2008 Nov 24.

PMID:
19063875
13.

Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.

Buttitta F, Felicioni L, Del Grammastro M, Filice G, Di Lorito A, Malatesta S, Viola P, Centi I, D'Antuono T, Zappacosta R, Rosini S, Cuccurullo F, Marchetti A.

Clin Cancer Res. 2013 Feb 1;19(3):691-8. doi: 10.1158/1078-0432.CCR-12-1958. Epub 2012 Dec 14.

14.

Rapid and efficient detection of EGFR mutations in problematic cytologic specimens by high-resolution melting analysis.

Hlinkova K, Babál P, Berzinec P, Majer I, Ilencikova D.

Mol Diagn Ther. 2011 Feb 1;15(1):21-9. doi: 10.2165/11586950-000000000-00000.

PMID:
21469767
15.

Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR.

Chung KP, Wu SG, Wu JY, Yang JC, Yu CJ, Wei PF, Shih JY, Yang PC.

Clin Cancer Res. 2012 Jun 15;18(12):3470-7. doi: 10.1158/1078-0432.CCR-11-2353. Epub 2012 Apr 17.

16.
17.

Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.

Cohen V, Agulnik JS, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, Miller WH Jr.

Cancer. 2010 Sep 15;116(18):4309-17. doi: 10.1002/cncr.25214.

18.

Screening for EGFR mutations in lung cancer, a report from India.

Sahoo R, Harini VV, Babu VC, Patil Okaly GV, Rao S, Nargund A, Venkataswamy E, Rao R, Kumar BS.

Lung Cancer. 2011 Sep;73(3):316-9. doi: 10.1016/j.lungcan.2011.01.004. Epub 2011 Feb 18.

PMID:
21315473
19.

Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.

Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M.

BMC Cancer. 2011 Sep 24;11:406. doi: 10.1186/1471-2407-11-406.

20.

Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.

Asano H, Toyooka S, Tokumo M, Ichimura K, Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, Hiraki A, Sugi K, Kiura K, Date H, Shimizu N.

Clin Cancer Res. 2006 Jan 1;12(1):43-8.

Items per page

Supplemental Content

Write to the Help Desk